Tropical disease experts report missed opportunity to transform global HIV/AIDS fight

December 9, 2011, American Society of Tropical Medicine and Hygiene

Global HIV/AIDS prevention and treatment efforts are missing a major opportunity to significantly improve health conditions in poor countries by simply adding low-cost care for the many other chronic and disabling diseases routinely afflicting and often killing these same patients, according to a panel of disease experts who spoke at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

"People want ; they do not understand why we silo diseases," said Judd Walson, a and infectious disease expert at the University of Washington. "If you die from , you don't care that your HIV was treated. Communities want us to leverage the resources we have to treat and prevent disease as effectively as possible."

Walson and his colleagues on the panel noted that many victims of HIV/AIDS also typically suffer from one or more of about 17 neglected, but burdensome, tropical diseases often called "diseases of " because they prey on the "bottom billion"—the world's poorest people. They include ailments such as trachoma, schistosomiasis, lymphatic filariasis, leishmaniasis, Chagas disease and onchocerciasis, all of which are either insect-borne disease, bacterial infections, or caused by parasitic worms.

Despite the illness and deaths attributable to these diseases, proposed US funding for fighting them was only about $155 million in 2011, or about 3 percent of the $5.6 billion invested in HIV/AIDS efforts. Moreover, the programs often exist in isolation from one another with, for example, many programs restricting support only to antiretroviral drugs to treat AIDS.

Yet tropical disease experts note that in places like sub-Saharan Africa, where neglected diseases affect 1.4 billion people, co-infections with HIV are common. And they see mounting evidence that dealing with multiple diseases at the same time and in the same place is more cost-effective and clinically beneficial.

Walson pointed to a program in Western Kenya that focused on a community suspected of having high levels of HIV but whose remote location made it hard to reach to conduct testing. The program promised access to free bed nets and water filters to those residents who came in for a test. In just six days, some 10,000 residents turned out for the free nets and filters. The result: 1181 people were found to be HIV positive and referred to care while thousands of people gained new tools for preventing malaria and water-borne diseases.

In another example of the potential benefits of targeting multiple problems in a single intervention, a study initially focusing on treatment for onchocerciasis, a parasitic disease also known as river blindness, was broadened to offer insecticide-treated bed nets (ITNs), malaria drugs and vitamin A. The study, which covered an area with 2.35 million people, increased bed net coverage by nine-fold.

Sten Vermund, Professor of Pediatrics and Director of the Vanderbilt Institute for Global Health, noted the need to address any co-infections that might increase HIV viral load. He pointed to studies linking higher viral load with a higher likelihood of transmitting HIV, and a low load with reduced disease progression and HIV transmission risk. He said a review of a wide number of studies revealed that treating a variety of co-infections, including TB, malaria, schistosomiasis, filariasis, herpes, gonorrhea and syphilis decreased viral load to varying degrees.

"If de-worming efforts for neglected diseases reduces the viral load even just a little, then you could expect some benefit for preventing or slowing HIV transmission," said Vermund. "But it's also helpful to keep in mind that a majority of people don't know they have HIV. An effective mass de-worming campaign could have huge effects without even knowing the community's HIV status."

Peter Hotez, ASTMH President and founding dean of the National School of Tropical Medicine at Baylor College of Medicine, and Alan Fenwick, Professor of Tropical Parasitology and Director of Schistosomiasis Control Initiative at the Department of Epidemiology at Imperial College of London, offered a presentation focused on improved treatment for schistosomiasis. Schistosomiasis is a preventable, chronic, inflammatory condition caused by a parasite infection that is found in approximately 220 million people, most of whom live in sub-Saharan Africa. The parasite swims in water and burrows into human skin on contact. It is linked to an estimated 280,000 deaths each year. In women, the disease often affects the cervix and vagina where it can cause infertility, painful intercourse, and post-coital bleeding. One type of schistosomiasis known as female urogenital schistosomiasis affects girls and young women and is associated with HIV infection.

"These women are at highest risk of HIV infection and should be the focus of public health interventions," said Fenwick.

The high prevalence of urogenital schistosomiasis appears to be associated with higher rates of HIV and the genital lesions seen with this type of schistosomiasis may contribute to the acquisition of HIV in women. The researchers believe schistosomiasis interventions can be seen as a type of /AIDS control, with mass treatment in girls aimed at preventing the onset of genital lesions.

In his President's address to the ASTMH meeting, Hotez challenged his colleagues to move beyond a focus on individual conditions to embrace a concerted campaign against the totality of tropical diseases. Referencing Bill Gates' call for adopting an "audacious goal" of eradicating malaria, Hotez called for expanding the "audacious goal" to ridding the world of all its neglected .

He portrayed neglected diseases as everyday manifestations of the Four Horsemen of the Apocalypse in that they cause pestilence, death, underlie famine and worsen the conditions of war. Hotez noted the importance of fighting disease to the success of international anti-poverty initiatives. "These diseases don't just occur in a setting of poverty; these diseases are a stealth cause of poverty in low and middle income countries," he said.

He quoted John Gardner, the Secretary of Health under President Lyndon Johnson, who said: "There are no better grounds on which we can meet other nations and demonstrate our own concern for peace and the betterment of mankind than in a common battle against disease.

In a separate presentation at ASTMH, Paul Farmer, founder of Partners in Health, also underscored the importance of attaching the fight against neglected diseases to a broader agenda.

"We need to understand the impact we can have when we link our understanding of improvements in people's lives to policy endeavors that can changes the lives of millions," he said. "Often this does not happen. The question is how can we build consensus in the scientific community and among our allies; how can we build coalitions to pull those policy levers more effectively? All of the diseases that affect the poor are neglected."

Explore further: Evidence shows NTD control can help in the fight against HIV/AIDS

Related Stories

Evidence shows NTD control can help in the fight against HIV/AIDS

July 27, 2011
There is a growing body of evidence revealing the connection between neglected tropical diseases (NTDs) and HIV/AIDS, prompting experts to call for greater integration of national NTD treatment programs with HIV/AIDS initiatives.

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Arachne646
not rated yet Dec 11, 2011
I know these parasitic diseases have complicated life cycles, and I'm skeptical of claims that they can be "eliminated" just by putting some more resources into fighting them. Anti-HIV programs have shown promise in developing rudimentary rural health care infrastructure in many places, though, and combination treatment is obviously good, though it seems likely any treated population would just become reinfected from the environment, barring water treatment, bed nets replaced when they tear, etc.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.